Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹1,055 Cr₹1,200 Cr₹1,017 Cr₹853 Cr₹713 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,055 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,055 Cr
Mar2025₹1,200 Cr
Mar2024₹1,017 Cr
Mar2023₹853 Cr
Mar2022₹713 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2026 ₹1,055 Cr
-12.10
Mar2025 ₹1,200 Cr
18.01
Mar2024 ₹1,017 Cr
19.20
Mar2023 ₹853 Cr
19.67
Mar2022 ₹713 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹12,864.2 Cr -3.1% -10.6% -18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-3.1%

-10.6%

-18.8%

SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses